Find uplifting stories about heroes, innovations, and solutions
1003 results for "hepatitis d"
A Kirkland biotechnology company just hit a major milestone that could bring hope to thousands living with a rare liver disease. The FDA has accepted EIT Pharma's new drug application for treating chronic hepatitis D.
A groundbreaking combination therapy has left nearly 9 in 10 hepatitis D patients with no detectable virus after two years of treatment. The results could transform care for a disease that often leads to liver failure within five years.
A groundbreaking hepatitis D treatment just won approval in China, offering hope to 12 million people worldwide living with one of the most severe forms of viral hepatitis. The drug represents a rare full-journey innovation, from basic science discovery to market-ready medicine, all developed domestically.
A new treatment for one of the deadliest forms of viral hepatitis just got approved in China, offering hope to 12 million people worldwide who had almost no options. The drug, developed entirely in China from discovery to delivery, blocks both hepatitis B and D viruses from entering liver cells.
New World Health Organization data shows hepatitis C deaths have fallen 12% globally since 2015, with childhood hepatitis B infections down to just 0.6%. Countries like Egypt, Georgia, and Rwanda are proving that eliminating this deadly disease is possible with the right commitment and tools.
A medication already being tested for hepatitis C shows promising results against hepatitis E, a deadly virus that kills 70,000 people yearly and has no approved treatment. Scientists discovered bemnifosbuvir stops the virus from replicating without harming healthy cells.
A groundbreaking hepatitis B treatment has achieved what was once thought impossible: completely clearing the virus from patients' bodies. One in five participants in recent trials are now virus-free, offering hope to 296 million people worldwide living with chronic hepatitis B.
After years without any approved therapies, adults living with chronic hepatitis delta virus now have hope with the FDA's approval of Hepcludex, the first treatment for one of the most severe forms of viral hepatitis. This breakthrough fills a critical gap for nearly 200,000 Americans who face rapid progression to serious liver complications.
New research reveals that a simple genetic test could identify who benefits most from vitamin D supplements to prevent diabetes. For people with specific gene variants, daily vitamin D reduced diabetes risk by nearly one-fifth.
After 18 years of free health screenings and advocacy, Ghanaian musician Okyeame Kwame earns official recognition as National Hepatitis Ambassador. His decades of service across health, trade, and culture prove celebrities can build lasting national impact.
England is set to become one of the first countries in the world to eliminate hepatitis C, a deadly liver virus that's been silently affecting tens of thousands. Simple treatments and innovative testing programs are driving this remarkable public health victory.
New research shows people with low vitamin D face 33% higher hospitalization rates for respiratory infections. The discovery offers a simple way to strengthen your immune system during flu season.
A simple fingerstick test for hepatitis B is just as accurate as traditional lab testing, and delivers results in 60 minutes instead of days. This breakthrough could save lives by bringing testing to remote communities where 254 million people worldwide need better access to care.
A major trial found vitamin D didn't stop COVID infections, but it may help reduce lingering symptoms weeks later. The discovery could offer hope to millions still struggling with long COVID.
A team of researchers across five countries just received $24 million to find a cure for hepatitis B, a virus that affects 300 million people worldwide. The five-year effort could finally bring hope to millions living with a disease that currently has no cure.
After 40 years of prevention-only treatments, European researchers are developing the first therapies that could free 254 million people from lifelong hepatitis B. Two major clinical trials show new immune-based approaches may finally achieve what vaccines alone couldn't: a functional cure.
Twenty years ago, hepatitis C was a devastating chronic disease that led to liver failure and death. Today, a short course of pills cures 95% of patients, thanks to scientists who refused to give up.
Researchers at UC San Francisco discovered how certain immune cells can cure chronic hepatitis B infections, solving a 15-year medical mystery. The breakthrough could help hundreds of millions of people worldwide beat a virus that kills over a million annually.
A 16-year study of nearly 800 adults found that maintaining healthy vitamin D levels may cut Alzheimer's risk in half. The simple solution could be as easy as getting more sunlight or taking a supplement.
Scientists discovered that higher vitamin D levels in middle age are linked to fewer toxic protein tangles in the brain 16 years later. The finding offers hope that something as simple as sunshine, fish, or supplements could help protect against Alzheimer's.
Showing 20 of 1003